Actinium's Chief Medical Officer to Participate in the Next Gen Immunotherapeutics Panel at ...

Retrieved on: 2024-05-03 23:19:32

Tags for this article:

Click the tags to see associated articles and topics

Actinium's Chief Medical Officer to Participate in the Next Gen Immunotherapeutics Panel at .... View article details on hiswai:

Excerpt

... monoclonal antibodies. The Company's lead radiopharmaceutical Iomab™-B will be used in preparing patients for hematopoietic stem cell transplant ...

Article found on: uk.news.yahoo.com

View Original Article